Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseases
- 29 May 2007
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 51 (6) , 652-664
Abstract
Growing evidence from tissue culture, animal, and clinical models suggests that the flavonoid‐rich fruits of the North American cranberry and blueberry (Vaccinium spp.) have the potential ability to limit the development and severity of certain cancers and vascular diseases including atherosclerosis, ischemic stroke, and neurodegenerative diseases of aging. The fruits contain a variety of phytochemicals that could contribute to these protective effects, including flavonoids such as anthocyanins, flavonols, and proanthocyanidins; substituted cinnamic acids and stilbenes; and triterpenoids such as ursolic acid and its esters. Cranberry and blueberry constituents are likely to act by mechanisms that counteract oxidative stress, decrease inflammation, and modulate macromolecular interactions and expression of genes associated with disease processes. The evidence suggests a potential role for dietary cranberry and blueberry in the prevention of cancer and vascular diseases, justifying further research to determine how the bioavailability and metabolism of berry phytonutrients influence their activity in vivo.Keywords
This publication has 77 references indexed in Scilit:
- Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated eventsThe Journal of Nutritional Biochemistry, 2006
- Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cellsBiochemistry and Cell Biology, 2005
- Cranberries inhibit LDL oxidation and induce LDL receptor expression in hepatocytesLife Sciences, 2005
- Comparative Effects of Food-Derived Polyphenols on the Viability and Apoptosis of a Human Hepatoma Cell Line (HepG2)Journal of Agricultural and Food Chemistry, 2005
- Cytotoxic Triterpenes and Sterol from the Fruit of Rabbiteye Blueberry (Vaccinium ashei)Food Science and Technology Research, 2004
- Protein-facilitated Export of Arachidonic Acid from Pig NeutrophilsJournal of Biological Chemistry, 1997
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997
- Cellular mechanisms involved in brain ischemiaCanadian Journal of Physiology and Pharmacology, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990